88 results
8-K
VTAK
Catheter Precision Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:20pm
Preferred to one thousand shares of Company Common Stock. The Series X Preferred has no voting rights. On the closing date of the Merger, the value … of any discount for lack of voting rights and ownership blockers, $90,098.96.
Also as of the Effective Date, the Board has named David Jenkins Chief
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:16pm
, and has no voting rights.
The shares of Series X Preferred Stock issued in the Merger were allocated as follows:
1. The total number of shares
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:15pm
convertible into one thousand (1,000) shares of Registrant Common Stock, subject to certain requirements, and has no voting rights.
The shares of Series
PRER14A
veaxvnx x657
3 Nov 22
Preliminary revised proxy
9:55pm
PREM14A
bzws xqj90wfn
23 Sep 22
Preliminary proxy related to merger
5:28pm
DEFA14A
56g9c97 r04fkaazgv
20 Sep 22
Additional proxy soliciting materials
5:23pm
8-K
uv6m5
20 Sep 22
Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split
5:22pm
424B5
nyuoi5xqp4o
2 Sep 22
Prospectus supplement for primary offering
5:17pm
8-K
EX-4.2
yulewms
22 Jul 22
Entry into a Material Definitive Agreement
8:35am